Drug intelligence / Profile preview

d-leucine

Development stage
Preclinical
Modality
Peptides, Small Molecules
Administration
Oral
01

Overview

D-leucine is the D-enantiomer of leucine, a branched-chain amino acid. Unlike its natural counterpart L-leucine, which is essential for protein synthesis and muscle growth, D-leucine is not commonly found in nature and is primarily synthesized for research and potential therapeutic applications. Recent preclinical studies have shown that D-leucine can potently terminate ongoing seizures in animal models without the sedative effects seen with traditional anticonvulsants like diazepam. Its mechanism of action appears to be distinct from known neuronal pathways involved in seizure control, suggesting a novel target or pathway. Beyond its experimental use as an anti-seizure agent, D-leucine has applications in dietary supplements for muscle recovery and as a chiral building block in pharmaceutical development[1][2][3][5][8].

Other names
(2R)-2-amino-4-methylpentanoic acid(R)-(−)-leucine(R)-leucineD-2-Amino-4-methylvaleric acidD2-Amino-4-methylvaleric acidD 2-Amino-4-methylvaleric acidD-LeucinD-Leuzin

Beyond the preview

Go deeper on d-leucine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on d-leucine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call